Research Article

Salivary IL-17A, IL-17F, and TNF-α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer

Figure 1

Differences in concentrations of IL-17A, IL-17F, and TNF-α between patients with head and neck cancer at different stages of disease. (a) There was a significant difference in salivary concentration of IL-17A () between patients with different disease stage, and post hoc tests showed significant differences between stage I/II patients as well as stage III and stage IV patients. (b) There was a significant difference in salivary concentration of IL-17F () between stages, and post hoc tests showed significant differences between stage I/II patients as well as stage IV patients and stage III patients. (c) There was a significant difference in salivary concentration of TNF-α () between stages, and post hoc tests showed significant differences between stage I/II patients and stage IV patients. , , _median.
(a)
(b)
(c)